美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=PANCREAZE"
符合检索条件的记录共 6 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
PANCREAZE 022523 001 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 24,600USP UNITS; 4,200USP UNITS; 14,200USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
PANCREAZE 022523 002 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 61,500USP UNITS; 10,500USP UNITS; 35,500USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
PANCREAZE 022523 003 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 98,400USP UNITS; 16,800USP UNITS; 56,800USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
PANCREAZE 022523 004 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 83,900USP UNITS; 21,000USP UNITS; 54,700USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
PANCREAZE 022523 005 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 149,900USP UNITS; 37,000USP UNITS; 97,300USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
PANCREAZE 022523 006 BLA PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) CAPSULE, DELAYED RELEASE;ORAL 15,200USP UNITS; 2,600USP UNITS; 8,800USP UNITS No No 2010/04/12 -- VIVUS INC Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database